These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23462049)

  • 1. Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.
    Matosin N; Frank E; Deng C; Huang XF; Newell KA
    Schizophr Res; 2013 May; 146(1-3):170-6. PubMed ID: 23462049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
    Matosin N; Fernandez-Enright F; Lum JS; Andrews JL; Engel M; Huang XF; Newell KA
    Schizophr Res; 2015 Aug; 166(1-3):212-8. PubMed ID: 26048293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.
    Matosin N; Fernandez-Enright F; Fung SJ; Lum JS; Engel M; Andrews JL; Huang XF; Weickert CS; Newell KA
    Acta Neuropathol; 2015 Jul; 130(1):119-29. PubMed ID: 25778620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age.
    Frank E; Newell KA; Huang XF
    Schizophr Res; 2011 May; 128(1-3):56-60. PubMed ID: 21334855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
    Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.
    Matosin N; Newell KA
    Neurosci Biobehav Rev; 2013 Mar; 37(3):256-68. PubMed ID: 23253944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.
    Kinney GG; O'Brien JA; Lemaire W; Burno M; Bickel DJ; Clements MK; Chen TB; Wisnoski DD; Lindsley CW; Tiller PR; Smith S; Jacobson MA; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
    J Pharmacol Exp Ther; 2005 Apr; 313(1):199-206. PubMed ID: 15608073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
    Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
    Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
    Akkus F; Treyer V; Ametamey SM; Johayem A; Buck A; Hasler G
    Schizophr Res; 2017 May; 183():95-101. PubMed ID: 27847228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.
    Rodriguez AL; Grier MD; Jones CK; Herman EJ; Kane AS; Smith RL; Williams R; Zhou Y; Marlo JE; Days EL; Blatt TN; Jadhav S; Menon UN; Vinson PN; Rook JM; Stauffer SR; Niswender CM; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2010 Dec; 78(6):1105-23. PubMed ID: 20923853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia.
    Nudmamud S; Reynolds GP
    Neurosci Lett; 2001 May; 304(1-2):9-12. PubMed ID: 11335042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
    Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
    Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
    Kinney GG; Burno M; Campbell UC; Hernandez LM; Rodriguez D; Bristow LJ; Conn PJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):116-23. PubMed ID: 12660307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
    Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?
    Ghose S; Gleason KA; Potts BW; Lewis-Amezcua K; Tamminga CA
    Am J Psychiatry; 2009 Jul; 166(7):812-20. PubMed ID: 19487395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    O'Leary DM; Movsesyan V; Vicini S; Faden AI
    Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Pinacho R; Vila E; Prades R; Tarragó T; Castro E; Ferrer I; Ramos B
    Schizophr Res; 2016 Nov; 177(1-3):37-43. PubMed ID: 27156240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
    Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
    J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.